169
Views
13
CrossRef citations to date
0
Altmetric
Review

Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States

, , , &
Pages 1129-1143 | Received 05 Aug 2019, Accepted 26 Nov 2019, Published online: 16 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Diana Canetti & Vincenzo Spagnuolo. (2021) An evaluation of cabotegravir for HIV treatment and prevention. Expert Opinion on Pharmacotherapy 22:4, pages 403-414.
Read now

Articles from other publishers (12)

Emily J. Ross, Renessa S. Williams, Michael Viamonte, John M. Reynolds, Dustin T. Duncan, Robert H. Paul & Adam W. Carrico. (2023) Overamped: Stimulant Use and HIV Pathogenesis. Current HIV/AIDS Reports.
Crossref
Sophie M. Coulter, Sreekanth Pentlavalli, Lalitkumar K. Vora, Yuming An, Emily R. Cross, Ke Peng, Kate McAulay, Ralf Schweins, Ryan F. Donnelly, Helen O. McCarthy & Garry Laverty. (2023) Enzyme‐Triggered l ‐ α / d ‐Peptide Hydrogels as a Long‐Acting Injectable Platform for Systemic Delivery of HIV/AIDS Drugs . Advanced Healthcare Materials 12:18.
Crossref
Parya Saberi, Marie C.D. Stoner, Shadi Eskaf, Samuel Ndukwe, Chadwick K. Campbell, John A. Sauceda & Karine Dubé. (2023) Preferences for HIV Treatment Formulations Among Young Adults With HIV in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes 92:2, pages e7-e10.
Crossref
Minyahil Woldu, Omary Minzi, Workineh Shibeshi, Aster Shewaamare & Ephrem Engidawork. (2022) Cardiometabolic syndrome in HIV-positive and HIV-negative patients at Zewditu Memorial Hospital, Addis Ababa, Ethiopia: a comparative cohort study. Cardiovascular Endocrinology & Metabolism 12:1.
Crossref
John Kanazawa, Sara Gianella, Susanna Concha-Garcia, Jeff Taylor, Andy Kaytes, Christopher Christensen, Hursch Patel, Samuel Ndukwe, Stephen A. Rawlings, Steven Hendrickx, Susan Little, Brandon Brown, Davey Smith & Karine Dubé. (2022) Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States. BMC Medical Ethics 23:1.
Crossref
Parya Saberi, Chadwick K. Campbell, John A. SaucedaSamuel NdukweKarine Dubé. (2022) Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings. AIDS Research and Human Retroviruses 38:8, pages 649-659.
Crossref
Karen Kolmodin MacDonell & Sylvie Naar. (2022) Self-Management Frameworks for Youth Living with Human Immunodeficiency Virus. Pediatric Clinics of North America 69:4, pages 759-777.
Crossref
I. T. Murkamilov, K. A. Aitbaev, V. V. Fomin, G. A. Murkamilova, F. A. Yusupov & A. I. Schastlivenko. (2022) Kidney damage in HIV infection: pathogenetic aspects, clinical and morphological variants and the role of antiretroviral therapy. HIV Infection and Immunosuppressive Disorders 14:1, pages 25-36.
Crossref
Sian Raubinger, Frederick J. Lee & Angie N. Pinto. (2022) HIV : the changing paradigm . Internal Medicine Journal 52:4, pages 542-549.
Crossref
Mary Clare Masters & Susan Ellen Cohn. (2021) Two-drug HIV regimens: more data still needed. The Lancet HIV 8:8, pages e454-e455.
Crossref
John T. KanazawaParya SaberiJohn A. SaucedaKarine Dubé. (2021) The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS Research and Human Retroviruses 37:2, pages 75-88.
Crossref
Ilya Nifant’ev, Andrei Siniavin, Eduard Karamov, Maxim Kosarev, Sergey Kovalchuk, Ali Turgiev, Sergey Nametkin, Vladimir Bagrov, Alexander Tavtorkin & Pavel Ivchenko. (2020) A New Approach to Developing Long-Acting Injectable Formulations of Anti-HIV Drugs: Poly(Ethylene Phosphoric Acid) Block Copolymers Increase the Efficiency of Tenofovir against HIV-1 in MT-4 Cells. International Journal of Molecular Sciences 22:1, pages 340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.